Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1067

1.

Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.

Moriya J, Wu X, Zavala-Solorio J, Ross J, Liang XH, Ferrara N.

J Vasc Surg. 2014 May;59(5):1402-9.e1-4. doi: 10.1016/j.jvs.2013.04.053. Epub 2013 Jul 13.

2.

Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.

Paquin-Veillette J, Lizotte F, Robillard S, Béland R, Breton MA, Guay A, Despatis MA, Geraldes P.

Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2291-2300. doi: 10.1161/ATVBAHA.117.309977. Epub 2017 Oct 26.

PMID:
29074590
3.

Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.

López-Díez R, Shen X, Daffu G, Khursheed M, Hu J, Song F, Rosario R, Xu Y, Li Q, Xi X, Zou YS, Li H, Schmidt AM, Yan SF.

Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1536-1547. doi: 10.1161/ATVBAHA.117.309714. Epub 2017 Jun 22.

PMID:
28642238
4.

Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.

Kuwahara G, Nishinakamura H, Kojima D, Tashiro T, Kodama S.

J Vasc Surg. 2013 Apr;57(4):1090-9. doi: 10.1016/j.jvs.2012.08.121. Epub 2012 Dec 7.

5.
6.

Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression.

Fujii T, Onimaru M, Yonemitsu Y, Kuwano H, Sueishi K.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2785-91. doi: 10.1152/ajpheart.00149.2008. Epub 2008 Apr 25.

PMID:
18441206
7.

Anti-vascular endothelial growth factor treatment induces blood flow recovery through vascular remodeling in high-fat diet induced diabetic mice.

Xiao L, Yan K, Yang Y, Chen N, Li Y, Deng X, Wang L, Liu Y, Mu L, Li R, Luo M, Ren M, Wu J.

Microvasc Res. 2016 May;105:70-6. doi: 10.1016/j.mvr.2016.01.005. Epub 2016 Jan 22.

PMID:
26808210
8.

VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.

Onimaru M, Yonemitsu Y, Fujii T, Tanii M, Nakano T, Nakagawa K, Kohno R, Hasegawa M, Nishikawa S, Sueishi K.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1685-96. doi: 10.1152/ajpheart.00015.2009. Epub 2009 Sep 4.

PMID:
19734356
9.

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.

Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM.

J Vasc Surg. 2009 Sep;50(3):608-16. doi: 10.1016/j.jvs.2009.05.049. Epub 2009 Jul 12.

11.
13.

Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.

Yan J, Tie G, Park B, Yan Y, Nowicki PT, Messina LM.

J Vasc Surg. 2009 Dec;50(6):1412-22. doi: 10.1016/j.jvs.2009.08.007. Epub 2009 Oct 17.

14.

Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors.

Tanii M, Yonemitsu Y, Fujii T, Shikada Y, Kohno R, Onimaru M, Okano S, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K.

Circ Res. 2006 Jan 6;98(1):55-62. Epub 2005 Nov 23.

15.

PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.

Lizotte F, Paré M, Denhez B, Leitges M, Guay A, Geraldes P.

Diabetes. 2013 Aug;62(8):2948-57. doi: 10.2337/db12-1432. Epub 2013 Apr 4.

16.

Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network.

Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K.

Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1603-9. Epub 2005 May 26.

17.

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM.

Am J Pathol. 1999 Feb;154(2):355-63.

18.

Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.

Huang PH, Chen CY, Lin CP, Wang CH, Tsai HY, Lo WY, Leu HB, Chen JW, Lin SJ, Chu PH.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):709-17. doi: 10.1161/ATVBAHA.112.300318. Epub 2013 Feb 14.

19.

Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K.

Circ Res. 2002 May 17;90(9):966-73.

20.

Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia.

Hopkins SP, Bulgrin JP, Sims RL, Bowman B, Donovan DL, Schmidt SP.

J Vasc Surg. 1998 May;27(5):886-94; discussion 895.

Supplemental Content

Support Center